`
Wednesday, 28 June 2017

Clinical Research News

  • Strategic site selection could help reduce study delays

    Clinical Research |  Opinion | By BioSpectrum Bureau | 0 Comment | 09 Oct, 2014

    With surveys indicating that 70 percent of clinical trials across Asia, Europe, Canada and Latin America experience delays and only 15 percent of Asian trials are completed on time1,2 â”...Read more

  • Rate of drug approvals dips down: Nature Study

    Clinical Research |  Analysis | By BioSpectrum Bureau | 0 Comment | 10 Jan, 2014

    Singapore: Nature Biotechnology has published a peer-reviewed paper co-authored by the Biotechnology Industry Organization (BIO) Industry Analysis and BioMedTracker (BMT) highlighting resul...Read more

  • CPR ventures into large molecule analytics

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 26 Mar, 2013

    Singapore: Clinical research company, CPR Pharma Services, launched a new laboratory, in Adelaide, Australia, to provide ligand binding assay service for for biomarkers, monoclonal antibodi...Read more

  • Is guinea pig theory an overhyped myth?

    Clinical Research |  News | By Rahul Koul Koul | 0 Comment | 30 Aug, 2014

    Singapore: Ms Radhika (name changed), a patient who has been a part of the clinical trials being done on a drug that could treat her, is happy about the opportunity. Although she doesn't hi...Read more

  • NZ can generate $300 mn from clinical trials by 2020

    Clinical Research |  Analysis | By Vipul Murarka | 0 Comment | 19 Nov, 2012

    New Zealand is taking steps to improve the environment surrounding the country's clinical trial domain. With no accurate records of revenues being generated from clinical trials in the coun...Read more

  • Patients back-out from trials fearing AV consent'

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 30 Aug, 2014

    Singapore: The discussion was led by Ms Suneela Thatte, president, ISCR, and Dr Bapsy, senior consultant and head of department, oncology, Apollo Hospitals. During the discussion, Dr Bapsy...Read more

  • Merck Serono, Quintiles sign clinical research deal

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 16 May, 2013

    Singapore: Merck Serono and Quintiles have signed a new, five-year clinical development agreement. This strategic collaboration is the first-of-its-kind between a biopharmaceutical company ...Read more

  • US diagnostic lab expands in China

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 10 Sep, 2014

    Singapore: ACM Global Central Laboratory, US-based diagnostic central laboratory, has expanded in China with the opening of ACM Shanghai, emerged after acquisition of Phoenix Pharma Central...Read more

  • Sihuan Pharmaceuticals inks a deal with Covance

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 07 Apr, 2015

    Singapore: Sihuan Pharmaceuticals recently announced that its subsidiary Shandong Xuanzhu has partnered with Covance, a contract research unit of Laboratory Corp of America Holdings to deve...Read more

  • Australia to get independent clinical trial regulatory authority

    Clinical Research |  Analysis | By Sheetal Sukhija | 0 Comment | 05 Sep, 2013

    Australia, often regarded by market experts as the most mature clinical research market in Asia Pacific, has leveraged substantially on the recent boom in the global life science industry. ...Read more

  • Pluristem's regenerative medicine convinces Japan PMDA

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 14 May, 2015

    Singapore: Pluristem Therapeutics, an Israel-based developer of placenta-based cell therapy products, has announced that Japan's Pharmaceuticals and Medical Devices Agency (PMDA) agreed wit...Read more

  • Quintiles officially opens regional HQ in China

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2016

    Singapore: Quintiles has officially opened Greater China Regional Headquarters, further expanding its ability to help Chinese companies expand globally and multinational companies succeed i...Read more

  • Australia launches website to enroll trial patients

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 18 Oct, 2012

    Singapore: Ms Tanya Plibersek, federal Minister for Health, and Mr Greg Combet, Minister for Innovation and Industry, Australia have launched a new website to encourage and facilitate patie...Read more

  • Dr Gautam Daftary: The Indian biologics pioneer

    Clinical Research |  Influencers | By Manasi Vaidya | 0 Comment | 14 Feb, 2013

    Indian company Bharat Serums and Vaccines boasts of a product portfolio that includes many firsts in India and the world and has carved out a prominent space in the world of biologicals and...Read more

  • BSA-CMR Survey: CROs hopeful despite stifled growth

    Clinical Research |  Analysis | By BioSpectrum Bureau | 0 Comment | 18 Sep, 2013

    The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

  • Indian government framing new clinical trial law

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 26 Jul, 2013

    Singapore: The Indian Supreme Court on July 26 heard a Public Interest Litigation (PIL) seeking a ban on drug trials in the country. The government has told the apex court of the country th...Read more

  • FDA approves Jubilant's molecule for drug trials

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 12 Aug, 2013

    Singapore: Indian pharmaceutical company based in Bangalore, Jubilant Biosys has said that the US Food and Drug Administration (FDA) has approved the novel molecule for clinical trials to t...Read more

  • Alchemia recruits patients for rectal cancer trial

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 05 Feb, 2013

    Singapore: Brisbane-based R&D company Alchemia has recruited the 390th patient for the pivotal phase III clinical trial of its lead cancer drug, HA-Irinotecan, as per its study protocol...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls